SG11201507134YA - Drug delivery devices and methods for drug delivery - Google Patents
Drug delivery devices and methods for drug deliveryInfo
- Publication number
- SG11201507134YA SG11201507134YA SG11201507134YA SG11201507134YA SG11201507134YA SG 11201507134Y A SG11201507134Y A SG 11201507134YA SG 11201507134Y A SG11201507134Y A SG 11201507134YA SG 11201507134Y A SG11201507134Y A SG 11201507134YA SG 11201507134Y A SG11201507134Y A SG 11201507134YA
- Authority
- SG
- Singapore
- Prior art keywords
- drug delivery
- methods
- devices
- delivery devices
- drug
- Prior art date
Links
- 238000012377 drug delivery Methods 0.000 title 2
- 238000000034 method Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Medical Informatics (AREA)
- Medicinal Preparation (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361794677P | 2013-03-15 | 2013-03-15 | |
PCT/US2014/028317 WO2014144066A1 (en) | 2013-03-15 | 2014-03-14 | Drug delivery devices and methods for drug delivery |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201507134YA true SG11201507134YA (en) | 2015-10-29 |
Family
ID=50631059
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201507134YA SG11201507134YA (en) | 2013-03-15 | 2014-03-14 | Drug delivery devices and methods for drug delivery |
Country Status (14)
Country | Link |
---|---|
US (2) | US9814671B2 (en) |
EP (1) | EP2968120A1 (en) |
JP (2) | JP6697376B2 (en) |
KR (2) | KR102270363B1 (en) |
CN (1) | CN105209012B (en) |
AU (1) | AU2014227914B2 (en) |
CA (1) | CA2902556C (en) |
IL (1) | IL240849B (en) |
IN (1) | IN2015DE07832A (en) |
MX (2) | MX2021001657A (en) |
NZ (1) | NZ711416A (en) |
RU (1) | RU2669407C2 (en) |
SG (1) | SG11201507134YA (en) |
WO (1) | WO2014144066A1 (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150043508A (en) | 2012-08-31 | 2015-04-22 | 타리스 바이오메디컬 엘엘씨 | Drug delivery systems and methods for treatment of prostate disease comprising gemicitabine |
US10137287B2 (en) | 2013-03-05 | 2018-11-27 | Taris Biomedical Llc | Drug delivery devices and methods for controlled drug release through device orifice |
IL299897B2 (en) | 2013-08-19 | 2024-02-01 | Taris Biomedical Llc | Multi-unit drug delivery devices and methods |
KR102338079B1 (en) | 2014-03-06 | 2021-12-09 | 타리스 바이오메디컬 엘엘씨 | Drug delivery systems and methods for treatment of bladder cancer with gemcitabine |
CN106456950A (en) | 2014-05-12 | 2017-02-22 | 塔里斯生物医药公司 | Drug delivery devices and methods |
EP3160442B1 (en) | 2014-06-26 | 2019-03-06 | TARIS Biomedical LLC | Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems |
WO2016205361A1 (en) * | 2015-06-15 | 2016-12-22 | Rowan University | Novel biodegradable and non-biodegradable 3d printed implants as a drug delivery system |
US11185670B2 (en) | 2016-01-26 | 2021-11-30 | Taris Biomedical Llc | Multi-lumen drug delivery devices |
WO2017151983A1 (en) | 2016-03-02 | 2017-09-08 | Taris Biomedical Llc | Osmotic drug delivery devices and methods of making osmotic drug delivery devices |
PL3452053T3 (en) | 2016-05-06 | 2023-05-08 | Taris Biomedical Llc | Method of treating lower tract urothelial cancer |
KR102564771B1 (en) * | 2017-02-01 | 2023-08-07 | 타리스 바이오메디컬 엘엘씨 | In vivo drug delivery device for drug delivery |
BR112020000832A2 (en) | 2017-07-25 | 2020-07-21 | Taris Biomedical Llc | methods to treat tumor metastasis |
KR20200085822A (en) | 2017-11-08 | 2020-07-15 | 타리스 바이오메디컬 엘엘씨 | Method of treatment and maintenance therapy for bladder cancer using gemcitabine |
AU2019315957A1 (en) | 2018-08-01 | 2021-02-18 | Taris Biomedical Llc | Methods of treating overactive bladder using trospium |
NL2021849B1 (en) * | 2018-10-22 | 2020-05-13 | Mat Nv | System and method for catheter based intervention |
BR112022007332A2 (en) | 2019-10-24 | 2022-07-05 | E Labombard Denis | EYE DEVICE, METHODS, COMPOSITION, BOX FOR CONTAINING AND DISPENSING AN EYE DEVICE AND KIT |
TW202400174A (en) | 2022-02-18 | 2024-01-01 | 美商塔里斯生物醫學有限責任公司 | Erdafitinib formulations and osmotic systems for intravesical administration |
WO2024092159A1 (en) | 2022-10-28 | 2024-05-02 | Taris Biomedical Llc | Methods of treating bladder cancer with gemcitabine |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4657536A (en) * | 1979-04-13 | 1987-04-14 | Regents Of The University Of Minnesota | Check valve catheter |
US5340590A (en) * | 1987-06-25 | 1994-08-23 | Alza Corporation | Delivery system with bilayer osmotic engine |
US5456679A (en) * | 1992-02-18 | 1995-10-10 | Alza Corporation | Delivery devices with pulsatile effect |
US5221278A (en) * | 1992-03-12 | 1993-06-22 | Alza Corporation | Osmotically driven delivery device with expandable orifice for pulsatile delivery effect |
PT621032E (en) | 1993-04-23 | 2001-01-31 | Novartis Ag | FARMACO CONTROLLED LIBERATION DISTRIBUTION DEVICE |
ZA981610B (en) * | 1997-03-24 | 1999-08-26 | Alza Corp | Self adjustable exit port. |
US6884429B2 (en) * | 1997-09-05 | 2005-04-26 | Isotechnika International Inc. | Medical devices incorporating deuterated rapamycin for controlled delivery thereof |
CA2520610A1 (en) * | 2003-03-31 | 2004-10-21 | Alza Corporation | Osmotic pump with means for dissipating internal pressure |
CN1822815B (en) * | 2003-07-10 | 2012-04-11 | 沃纳奇尔科特(爱尔兰)有限公司 | Intravaginal drug delivery devices |
AU2004277980A1 (en) | 2003-09-30 | 2005-04-14 | Alza Corporation | Osmotically driven active agent delivery device providing an ascending release profile |
US8801694B2 (en) | 2005-08-11 | 2014-08-12 | Massachusetts Institute Of Technology | Intravesical drug delivery device |
ATE498027T1 (en) * | 2005-12-07 | 2011-02-15 | Univ Ramot | COMPOSITE BODIES THAT RELEASE ACTIVE INGREDIENTS |
PL2359808T3 (en) | 2006-08-09 | 2013-10-31 | Intarcia Therapeutics Inc | Osmotic delivery systems and piston assemblies |
CA2698143C (en) * | 2007-06-26 | 2016-01-19 | Warner Chilcott Company, Llc | Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs |
EA201070703A1 (en) | 2007-12-11 | 2010-12-30 | Массачусетс Инститьют Оф Текнолоджи | IMPLANTABLE DEVICE FOR DELIVERY OF MEDICATION AND METHODS OF TREATMENT OF URINARY BUBBLE AND OTHER BODY CAVITY OR TUBULAR ORGANS |
EP2307071B1 (en) * | 2008-06-20 | 2015-08-12 | Cook Biotech Incorporated | Composite extracellular matrix materials and medical products formed therefrom |
EA201170297A1 (en) | 2008-08-09 | 2011-08-30 | Массачусетс Инститьют Оф Текнолоджи | IMPLANTABLE DEVICE FOR THE DELIVERY OF MEDICINES AND THE METHOD OF TREATMENT OF MALE URINS AND THE ENVIRONMENTAL TISSUES |
WO2010151893A1 (en) | 2009-06-26 | 2010-12-29 | Taris Biomedical, Inc. | Implantable drug delivery devices and methods of making the same |
US8721621B2 (en) | 2009-09-10 | 2014-05-13 | Taris Biomedical, Inc. | Systems and methods for deploying devices to genitourinary sites |
US9017312B2 (en) * | 2009-09-10 | 2015-04-28 | Taris Biomedical Llc | Implantable device for controlled drug delivery |
US8167836B2 (en) | 2009-12-08 | 2012-05-01 | Taris Biomedical, Inc. | Tissue expander configured for drug delivery |
SI2512581T1 (en) * | 2009-12-17 | 2021-09-30 | Taris Biomedical Llc | Implantable device with intravesical tolerability |
US20110218488A1 (en) | 2010-03-05 | 2011-09-08 | Taris Biomedical, Inc. | Systems and Methods for Implanting Devices in the Bladder and Other Genitourinary Sites |
WO2012009685A2 (en) * | 2010-07-15 | 2012-01-19 | Virtual Beam, Inc. | Directional information search from a mobile device |
WO2012019155A1 (en) | 2010-08-05 | 2012-02-09 | Taris Biomedical, Inc. | Ureteral stent drug delivery device, kit, and method |
US9457176B2 (en) | 2010-10-06 | 2016-10-04 | Taris Biomedical Llc | Implantable drug delivery device with bladder retention feature |
WO2012048114A1 (en) * | 2010-10-06 | 2012-04-12 | Taris Biomedical, Inc. | Time-selective bioresorbable or collapsible drug delivery systems and methods |
US9114111B2 (en) | 2011-01-10 | 2015-08-25 | Allergan, Inc. | Methods for sustained treatment of bladder pain and irritative voiding |
US9107816B2 (en) * | 2011-02-04 | 2015-08-18 | Taris Biomedical Llc | Implantable device for controlled dissolution and diffusion of low solubility drug |
US20130030354A1 (en) * | 2011-07-28 | 2013-01-31 | The Trustees Of Columbia University In The City Of New York | Systems, methods, and devices for in vivo delivery using remote actuation of implantable hydrogel mems devices |
US9533101B2 (en) | 2013-03-14 | 2017-01-03 | Leonard Allen Massey, JR. | Multi-cycle and auto-disable syringe and method of use thereof |
IL299897B2 (en) | 2013-08-19 | 2024-02-01 | Taris Biomedical Llc | Multi-unit drug delivery devices and methods |
-
2014
- 2014-03-14 SG SG11201507134YA patent/SG11201507134YA/en unknown
- 2014-03-14 NZ NZ711416A patent/NZ711416A/en unknown
- 2014-03-14 KR KR1020157029413A patent/KR102270363B1/en active IP Right Grant
- 2014-03-14 RU RU2015141361A patent/RU2669407C2/en active
- 2014-03-14 CA CA2902556A patent/CA2902556C/en active Active
- 2014-03-14 US US14/770,494 patent/US9814671B2/en active Active
- 2014-03-14 CN CN201480012405.5A patent/CN105209012B/en active Active
- 2014-03-14 MX MX2021001657A patent/MX2021001657A/en unknown
- 2014-03-14 WO PCT/US2014/028317 patent/WO2014144066A1/en active Application Filing
- 2014-03-14 KR KR1020217019397A patent/KR102339132B1/en active IP Right Grant
- 2014-03-14 AU AU2014227914A patent/AU2014227914B2/en active Active
- 2014-03-14 JP JP2016502759A patent/JP6697376B2/en active Active
- 2014-03-14 MX MX2015012250A patent/MX2015012250A/en unknown
- 2014-03-14 EP EP14721115.5A patent/EP2968120A1/en active Pending
-
2015
- 2015-08-26 IL IL240849A patent/IL240849B/en active IP Right Grant
- 2015-09-01 IN IN7832DE2015 patent/IN2015DE07832A/en unknown
-
2017
- 2017-10-31 US US15/799,204 patent/US10517816B2/en active Active
-
2018
- 2018-11-28 JP JP2018222670A patent/JP6746665B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
MX2015012250A (en) | 2015-12-01 |
JP2019051368A (en) | 2019-04-04 |
IL240849B (en) | 2020-04-30 |
CN105209012B (en) | 2019-02-01 |
IL240849A0 (en) | 2015-10-29 |
AU2014227914B2 (en) | 2018-05-10 |
BR112015022427A2 (en) | 2017-07-18 |
KR20210080608A (en) | 2021-06-30 |
US20160008271A1 (en) | 2016-01-14 |
NZ711416A (en) | 2018-02-23 |
KR20150130534A (en) | 2015-11-23 |
US10517816B2 (en) | 2019-12-31 |
US20180049975A1 (en) | 2018-02-22 |
US9814671B2 (en) | 2017-11-14 |
RU2015141361A (en) | 2017-04-20 |
JP2016513731A (en) | 2016-05-16 |
KR102339132B1 (en) | 2021-12-13 |
EP2968120A1 (en) | 2016-01-20 |
CA2902556A1 (en) | 2014-09-18 |
WO2014144066A1 (en) | 2014-09-18 |
RU2015141361A3 (en) | 2018-03-20 |
KR102270363B1 (en) | 2021-06-29 |
JP6697376B2 (en) | 2020-05-20 |
IN2015DE07832A (en) | 2016-04-22 |
MX2021001657A (en) | 2022-04-21 |
JP6746665B2 (en) | 2020-08-26 |
CA2902556C (en) | 2021-06-22 |
RU2669407C2 (en) | 2018-10-11 |
CN105209012A (en) | 2015-12-30 |
AU2014227914A1 (en) | 2015-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL282042A (en) | Multi-unit drug delivery devices and methods | |
HK1211517A1 (en) | Drug delivery device | |
HK1211520A1 (en) | Drug delivery device | |
IL240849A0 (en) | Drug delivery devices and methods for drug delivery | |
SG11201508647UA (en) | Drug delivery device | |
EP2961469A4 (en) | Drug delivery device | |
HK1211519A1 (en) | Drug delivery device | |
GB201313782D0 (en) | Drug delivery device | |
SG10201708522SA (en) | Drug delivery devices with drug-permeable component and methods | |
AP2016009223A0 (en) | Drug delivery system | |
IL244286B (en) | Medicament delivery device | |
GB201319681D0 (en) | System and method for drug delivery | |
SG11201600371XA (en) | Drug delivery device | |
HK1219451A1 (en) | Drug delivery device | |
HK1219450A1 (en) | Drug delivery device | |
HK1219682A1 (en) | Drug delivery device | |
HK1219685A1 (en) | Drug delivery device | |
HK1219681A1 (en) | Drug delivery device | |
HK1219680A1 (en) | Drug delivery device | |
GB2519596B (en) | Medicament Delivery device | |
EP2968884A4 (en) | Device and method for delivering medicaments | |
HK1221921A1 (en) | Drug delivery device | |
HK1223052A1 (en) | Drug delivery device | |
IL245007A0 (en) | Drug delivery device | |
GB201404358D0 (en) | Improvements in drug delivery inhalar devices |